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Abstract
Introduction: One of the most challenging safety issues in the manufacture of cell based medicinal products is
the control of microbial risk as cell-based products cannot undergo terminal sterilization. Accordingly, sensitive and
reliable methods for detection of microbial contamination are called for. As mitochondrial function has been
shown to correlate with the viability and functionality of human mesenchymal stem cells (hMSCs) we have studied
the use of a mitochondrial inner membrane potential sensitive dye for detecting changes in the function of
mitochondria following infection by bacteria.
Methods: The effect of bacterial contamination on the viability of bone marrow-derived mesenchymal stem cells
(BMMSCs) was studied. BMMSC lines were infected with three different bacterial species, namely two strains of
Pseudomonas aeruginosa, three strains of Staphylococcus aureus, and three strains of Staphylococcus epidermidis. The
changes in viability of the BMMSCs after bacterial infection were studied by staining with Trypan blue, by
morphological analysis and by monitoring of the mitochondrial inner membrane potential.
Results: Microscopy and viability assessment by Trypan blue staining showed that even the lowest bacterial
inocula caused total dissipation of BMMSCs within 24 hours of infection, similar to the effects seen with bacterial
loads which were several magnitudes higher. The first significant signs of damage induced by the pathogens
became evident after 6 hours of infection. Early changes in mitochondrial inner membrane potential of BMMSCs
were evident after 4 hours of infection even though no visible changes in viability of the BMMSCs could be seen.
Conclusions: Even low levels of bacterial contamination can cause a significant change in the viability of BMMSCs.
Moreover, monitoring the depolarization of the mitochondrial inner membrane potential may provide a rapid tool
for early detection of cellular damage induced by microbial infection. Accordingly, mitochondrial analyses offer
sensitive tools for quality control and monitoring of safety and efficacy of cellular therapy products.
Introduction
Stem cell therapies have raised hopes for the develop-
ment of viable alternatives for the treatment of many
severe degenerative and inflammatory conditions that
currently cannot be cured or alleviated by traditional
medicine [1-5]. However, there are still many important
issues that need to be solved before the transfer of these
advanced cellular therapies from the laboratory to clinics
can be successfully achieved. One of the major challenges
of such products and therapies is ensuring product safety
while maintaining efficacy since viable stem cell-based
products cannot undergo terminal sterility prior to
implantation and use [6]. Accordingly, the development
of aseptic manufacturing processes and process controls
is pivotal to the successful translation of research into
clinical practice [7]. In addition, the short shelf-life of
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products calls for the development of rapid methods to
detect bacterial contamination in a matter of hours [8,9].
Even though the incidents of microbial contamination
of cell products seem to be rare, the risk of contamina-
tion is a critical issue since the consequences to patient
health may be unpredictable and even devastating
[10-16]. Currently, there is little or no evidence to pre-
dict the long-term outcomes of possible infections after
cell implantation. Therefore, uncertainties of possible
further transmission of infectious agents from cell or tis-
sue implants to patient exist. Moreover, microbial
damage to stem cell products prior to implantation may
well lead to unpredictable consequences in the efficacy
of the implanted cells. Accordingly, strict requirements
set by regulatory agencies for the manufacture of cell-
based products, which must be performed according to
the principles of good manufacturing practices or good
tissue practices [17]. Even so, the most common site for
contamination is the in vitro expansion and manipula-
tion of cells [14,15], and the most frequent sources of
contamination are human skin, the environment, cloth-
ing, and gowning of hospital staff [12,15,18,19]. A vari-
ety of different pathogens have been isolated from
cellular products, and the most common is coagulase-
negative Staphylococcus spp. [10-16]. Moreover, a recent
study has elucidated the ability of different pathogens,
namely S. aureus, S. epidermidis, and Pseudomonas aer-
uginosa, to adhere to a biomaterial surface in the pre-
sence and absence of macrophages [20]. Despite the
presence of macrophages, osteoblast-like cells lost the
race of growth area on the biomaterial surface in the
presence of S. aureus or P. aeruginosa, but the cells sur-
vived about 48 hours in the presence of S. epidermidis.
These findings highlight the importance of microbial
risk management in the prevention of biomaterial-asso-
ciated infections.
Regulatory demands for the manufacture of stem cell-
based medicinal products in the European Union dictate
certain requirements for their quality, safety, and efficacy
[21]. However, even though there are a number of estab-
lished methods for the control of conventional biological
medicinal products, most of them are poorly applicable to
the control of the manufacturing processes of cell-based
products. Moreover, methods that can be used are often
laborious and time-consuming [22-25]. Therefore, one
possible avenue to be explored in microbial risk manage-
ment is the development of methods for monitoring of the
mitochondrial status of the cells in the intended product.
Mitochondria are the powerhouses of cell and are respon-
sible for the main energy production and are also an
important regulator of apoptosis [26-28]. In addition, it
has recently been shown that, in stem cell biology, mito-
chondria have a special role in the regulation of the ulti-
mate fate of stem cells [29-33]. Accordingly, we have
focused on mitochondrial analysis as a tool for measuring
the efficacy and potency of stem cell-based cellular pro-
ducts intended for clinical applications [33]. Recently, we
have shown that by analyzing mitochondrial inner mem-
brane potential (ΔΨm) it is possible to detect early changes
in viability and also to predict the osteogenic differentia-
tion potency of human mesenchymal stem cells (hMSCs).
We therefore postulate that monitoring of ΔΨm could also
be used as a tool to detect early changes in viability of
infected hMSCs and thus monitor the microbiological
safety of stem cell products.
In the present study, the viability of human bone mar-
row-derived human mesenchymal stem cells (BMMSCs)
was studied after deliberate and controlled cell culture
infection in co-culture with eight different bacterial strains.
The bacteria included two strains of P. aeruginosa, three
strains of Staphylococcus aureus, and three strains of
Staphylococcus epidermidis. P. aeruginosa, which is a
Gram-negative rod, and the Gram-positive cocci S. aureus
and S. epidermidis have been shown to be common con-
taminants of cell products and in the hospital environment
[10-16,34]. Two of the bacterial strains had previously
been isolated from discarded, contaminated batches of
blood products, making them biologically relevant models
for studying the contamination process of stem cell cul-
tures. The effects of the bacterial strains on ΔΨm, cell
morphology, and plasma membrane integrity of BMMSCs
were studied.
Materials and methods
BMMSC isolation and culture
BMMSC lines 407, 412, and 470 were isolated from unaf-
fected bone sites of patients who underwent surgery for
osteoarthritis at Oulu University Hospital in Finland.
These cell lines have been approved for research use by
permission of the Northern Ostrobothnia Hospital District
Ethical Committee. Samples from bone marrow were sus-
pended in a proliferation medium containing alpha mini-
mum essential medium (aMEM) (Sigma-Aldrich, St.
Louis, MO, USA) buffered with 20 mM HEPES and con-
taining 10% heat-inactivated fetal bovine serum (FBS),
100 U/mL penicillin, 0.1 mg/mL streptomycin, and 2 mM
L-glutamine. The suspension was transferred into cell cul-
ture flasks, and BMMSCs were allowed to attach for 48
hours at 37°C under 5% CO2 and 20% O2. Nonattached
cells were removed by changing fresh medium, and
attached cells were cultured at the bottom of the flask
until they reached a 70% to 80% confluence. The medium
was changed twice a week, and cells from passages 3 to 5
were used in experiments.
Flow cytometric analysis of surface antigens
The BMMSCs were characterized according to the mini-
mal criteria panel of surface antigens proposed by the
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Mesenchymal and Tissue Stem Cell Committee of the
International Society for Cellular Therapy [35]. BMMSC
lines 407, 412, and 470 were detached from culture flasks
and suspended in phosphate-buffered saline (PBS) + 0.5%
bovine serum albumin (BSA) (100,000 cells/mL). Conju-
gated antibodies were incubated for 20 minutes at room
temperature: CD90 (FITC; StemCell Technologies, Van-
couver, BC, Canada), CD73 (PE; BD Biosciences, San Jose,
CA, USA), HLA-ABC (APC; BD Biosciences), and CD105
(FITC; Abcam, Cambridge, UK). Negative surface antigens
for hMSCs were incubated simultaneously as a group in
the same sample: HLA-DR (PE; BD Biosciences), CD34
(PE; BD Biosciences), CD45 (PE; BD Biosciences), CD14
(PE; BD Biosciences), and CD19 (PE; BD Biosciences).
After incubation, cells were washed with PBS + 0.5% BSA
and analyzed by using a FACSCalibur instrument (Becton,
Dickinson and Company, Franklin Lakes, NJ, USA),
equipped with a laser emitting at 488, 633, and 407 nm.
FITC, PE, and APC channels were used to detect the
emission of conjugated surface antigens. Flow cytometric
data were analyzed with FlowJo. Cell debris was gated out
from all samples. On the basis of isotype controls and
unlabeled cells, the gates for positive cells were defined.
Bacterial strains and cultivation condition
P. aeruginosa PA01 (VTT E-84219), S. aureus Cowan I
(DSM 20372), and S. epidermidis ATCC 14990 were
obtained from commercial culture collections. S. aureus
KK1089 and S. epidermidis KK1087 were isolated from
discarded, contaminated batches of thrombocyte prepara-
tions. The bacterial strains were stored in skim milk
suspension at −80°C. Before co-culture experiments, bac-
teria were plated onto trypticase soy agar (TSA) plates
(Tammer Tutkan Maljat Ltd., Tampere, Finland) and cul-
tivated at 37°C overnight. Following incubation, a single
colony was inoculated into 5 mL of soy casein broth
(Tammer Tutkan Maljat Ltd. Tampere). The bacterial sus-
pensions were cultivated at 37°C overnight. The next
morning, bacteria were pelleted by centrifuging at 2,465g
for 10 minutes, washed twice with 10 mL of PBS, pH 7.2,
and finally suspended in 1 mL of PBS. The bacterial sus-
pensions were adjusted to an optical density of 1.0 at A600
nm by Shimadzu UV-1700 Pharma Spec spectrophot-
ometer (Shimadzu Corporation, Kyoto, Japan). Based on
previous experience, this corresponds to an order of mag-
nitude of 108 bacteria/mL. Viable counting of bacterial
suspensions in different experiments showed that bacterial
numbers ranged from 9 × 107 to 3 × 108 CFU/mL for
S. aureus strains, from 1 × 108 to 5 × 108 CFU/mL for
S. epidermidis strains, and from 4 × 108 to 7 × 108 CFU/
mL for P. aeruginosa PA01. Series of 10-fold dilutions of
all bacterial suspensions were performed in PBS, and three
dilutions of each bacterial strain were used to infect
BMMSCs. Small bacterial inocula (approximately 101 to
103 CFU) were used in order to simulate the aseptic cell
production process, in which contaminations are most
likely to derive from infection with only a few bacterial
cells, followed by bacterial multiplication in the nutrient-
rich cell culture medium. Moreover, previous studies on
the interaction of bacteria with MSCs or osteoblast-like
cells have similarly used bacterial amounts ranging from
3 × 102 to 1 × 103 [20,36].
P. aeruginosa ATCC9027, S. aureus ATCC6538, and S.
epidermidis ATCC12228, which are available as certified
reference material, were obtained from Microbiologics
(Labema OY, Kerava, Finland as lyophilized preparations
that contain a specified number of bacteria. The prepara-
tions were dissolved in accordance with the instructions of
the manufacturer. The number of recovered bacteria was
verified by viable counting. The final amounts of bacteria
used were 2 × 102 CFU/mL for P. aeruginosa ATCC9027,
4 × 102 CFU/mL for S. aureus ATCC6538, and 3 × 102
CFU/mL for S. epidermidis ATCC12228.
Bacterial infection of BMMSCs
BMMSCs were first cultivated as described above with
antibiotics and then were washed with PBS, trypsinized
from culture flasks, and suspended in the expansion med-
ium without antibiotics. BMMSCs were plated on clear
96-well plates for Trypan blue staining and microscope
analysis and in parallel on black (clear bottom) 96-well
plates for ΔΨm analysis. BMMSCs were plated as 10,000
cells per well and cultured overnight at 37°C under 5%
CO2 and 20% O2. Bacterial dilutions corresponding
approximately to 101, 102, or 103 bacteria per well were
inoculated, each individual strain separately, into the 96-
well plates in which BMMSCs had been grown overnight.
For the ΔΨm analysis, carbonyl cyanide m-chlorophenyl-
hydrazone (CCCP) (Sigma-Aldrich; 10 μM) was used as a
positive control. All treatments were performed as four
independent replicates. The ΔΨm analysis was performed
after 4 hours of infection and Trypan blue staining, and
observation of cellular morphology was performed after 3,
4, 6, and 24 hours of infection.
Determination of bacterial growth
Bacterial growth was determined after 4 and 24 hours of
infection of the BMMSC line 407. As a control, bacterial
growth was determined also after 4- and 24-hour incu-
bation under identical culture conditions and in a med-
ium not containing BMMSCs. Series of 10-fold dilutions
of bacterial suspensions were performed in PBS from all
of the analyzed samples, and bacteria from different
dilutions were plated onto TSA plates and cultivated at
37°C overnight. The next morning, colonies were calcu-
lated and the number of CFU was determined. Bacterial
loads after incubation were compared with bacterial
amounts in the inocula.
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Analysis of mitochondrial inner membrane potential
The infection of BMMSCs was terminated after 4 hours by
removing the bacterium-containing medium and washing
two times with PBS. After washing, the mitochondrial
inner membrane potential sensitive dye enhanced 5,5’,6,6’-
tetrachloro-1,1’,3,3’-tetraethylbenzimidazolcarbocyanine
iodide (JC-10) (Enzo Life Sciences, New York, NY, USA)
was used. The JC-10 staining solution (5 μM) was pre-
pared by diluting the JC-10 stock solution (1.7 mM in
DMSO) into the expansion medium. The staining solution
was mixed well, added to the cells, and incubated for 60
minutes at room temperature. Following incubation, the
staining solution was removed and PBS was added. Expan-
sion medium in wells without cells was used as a back-
ground, and JC-10 staining was performed as for the wells
with BMMSCs. The JC-10 signal was detected by a fluor-
escence plate reader (Victor2 1420 Multilabel counter;
Wallac, now part of PerkinElmer Inc., Waltham, MA,
USA). Fluorescence was excited at 488 nm, and the emis-
sion was measured at 595 ± 42 nm and 535 ± 30 nm. The
background fluorescences of 595 and 535 nm from wells
without cells were subtracted from the analyzed samples.
The 595 nm/535 nm emission ratio was determined from
four different replicates, and the ratio of infected or
CCCP-treated cells was compared with the control cells.
CCCP was used to depolarize ΔΨm, which was seen as a
decrease in the 595 nm/530 nm emission ratio.
Trypan blue staining
Trypan blue (Stem Cell Technologies, Vancouver, BC,
Canada) was diluted 1:100 in PBS and added onto the
cells. Trypan blue staining, together with photography,
was performed after 3, 4, 6, and 24 hours of infection.
Cells were studied by using an inverted microscope Leica
DM IL LED (Leica, Wetzlar, Germany) and photographed
with a Leica DFC 420 digital microscope camera.
Statistics
Statistical analysis and all diagrams were performed by
using the OriginPro version 8 (OriginLab Corporation,
Northampton, MA, USA). JC-10 data are presented as
mean ± standard deviation (SD) of the results from four
independent replicates. The significance level was deter-
mined by two-sample t test. A P value of less than 0.05
was considered statistically significant.
Results
Even low numbers of pathogens damage BMMSCs within
24 hours
Bacterial infection of BMMSCs was studied in three
BMMSC lines, namely 407 (female donor, 57 years old),
412 (male donor, 51 years old), and 470 (female donor, 70
years old). All of the BMMSC lines expressed cell surface
antigens characteristic for hMSCs as proposed by the
Mesenchymal and Tissue Stem Cell Committee of the
International Society for Cellular Therapy [35] (Table 1).
Bacteria were first incubated in three different amounts
with BMMSCs (line 412). To determine the period of time
that the bacterial contamination needs to induce total dis-
sipation of BMMSCs even with the lowest bacterial load,
we first decided to monitor the infection of BMMSCs for
24 hours. The effect of infection was compared with the
uninfected control of BMMSCs (Figure 1a). The results
show that P. aeruginosa PA01 caused total destruction of
BMMSCs within 24 hours of infection (Figure 1b). S. aur-
eus Cowan I and S. aureus KK1089 produced enormous
aggregates, and cell death of BMMSCs was evident due to
the appearance of Trypan blue-positive nuclei (Figure 1c,
d). S. epidermidis ATCC 1499 and S. epidermidis KK1087
also caused total dissipation of BMMSCs after 24 hours of
infection (Figure 1e, f). All pathogens caused a similar
destruction of BMMSCs regardless of the initial amount
of inoculated bacteria. This experiment was repeated with
the BMMSC lines 407 and 470 and the results were con-
sistent (data not shown).
Decrease in viability of BMMSCs after 6 hours of infection
The early effects of bacterial contamination on the viability
of BMMSCs were studied by inoculating cells with
approximately 103 bacteria per well and monitoring the
cellular changes during the first 6 hours. Inoculated patho-
gens appeared to spend 3 hours in a lag phase most prob-
ably adapting to new culture conditions as during that
time there were no differences between control cells
(Figure 2a) and bacterium-infected cells (Figure 2b-f,
photographs on the left column). After 6 hours of infec-
tion, however, changes in BMMSC viability became
evident when compared with uninfected control cells (Fig-
ure 2a, photograph on the right column). P. aeruginosa
PA01 caused a clear decrease in viability as determined by
Trypan blue staining, and morphological changes in the
BMMSCs were evident (Figure 2b, photograph on the
right column). The morphological changes were seen as a
rounding of the cells and loss of the characteristic spindle-
like cell morphology. S. aureus Cowan I and S. aureus
KK1089 promoted formation of small aggregates after 6
hours of infection, and some Trypan blue-positive nuclei
were evident, whereas the morphology of BMMSCs
appeared to stay normal (Figure 2c, d, photographs on
right). S. aureus KK1089 showed the formation of aggre-
gates in experiments in which lower numbers of bacteria
(101 and 102) were initially seeded, but such aggregates
were not evident with S. aureus Cowan I (data not
shown). Similar kinds of aggregates were also evident
when S. aureus was grown in the medium without
BMMSCs (data not shown). The infection of BMMSCs
with S. epidermidis ATCC 14990 and S. epidermidis
KK1087 showed some Trypan blue-positive staining of
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nuclei, but no clear morphological changes were evident in
BMMSCs when compared with the uninfected control
BMMSCs (Figure 2e, f, photographs on the right column).
Pathogen-induced depolarization of ΔΨm precedes major
changes in cell morphology or decreases in viability of
BMMSCs
BMMSC lines 407, 470, and 412 were used to study the
early effects of pathogen contamination on the state of
mitochondrial energy of BMMSCs. Based on the above
results with Trypan blue staining and analysis of cell mor-
phology, which showed that changes begin to appear in the
viability of BMMSCs after 6 hours of infection, the 4-hour
time point was chosen for ΔΨm analysis. The aim was to
investigate whether changes in mitochondrial energy state
precede the changes that can be detected by traditional
Trypan blue staining. In these experiments, CCCP treat-
ment was used as a positive control to depolarize the ΔΨm
(Figure 3a). It was evident that the S. aureus strains had a
slightly different effect on the cells. Namely, with S. aureus
Cowan I only, the BMMSC line 412 showed a significant
decrease in ΔΨm from 100% ± 5.8% to 84.9% ± 6.6% when
the highest inoculum of S. aureus Cowan I was used and
the ΔΨm of infected BMMSCs was compared with the
ΔΨm of control BMMSCs (P <0.05) (Figure 3b). Instead,
S. aureus KK1089 induced a significant decrease in ΔΨm
under most experimental conditions in all three BMMSC
lines even before any major changes in viability or mor-
phology were evident (Figure 3c). The initial inoculum of
103 of S. aureus KK1089 caused significant depolarization
of ΔΨm in all BMMSC lines from 100% ± 5.8% to 56.8% ±
7.4% (P <0.01) in BMMSC 407, from 100% ± 5.8% to
77.7% ± 2.6% (P <0.001) in BMMSC 412, and from 100% ±
5.8% to 85.3% ± 4.3% (P <0.01) in BMMSC 470. S. epider-
midis ATCC 14990 and S. epidermidis KK1087 also
induced significant depolarization of ΔΨm in all three
BMMSC lines at all microbial loads when compared with
uninfected control cells (Figure 3d, e). The initial bacterial
load of 103 of S. epidermidis KK1087 caused dramatic
decreases of ΔΨm in 407, 412, and 470 BMMSC lines from
100% ± 5.8% to 58.1% ± 20.1% (P <0.05), from 100% ±
5.8% to 73.6% ± 8.6% (P <0.01), and from 100% ± 5.8% to
81.1% ± 9.6% (P <0.05), respectively. P. aeruginosa PA01
caused depolarization of ΔΨm in all BMMSC lines at
higher bacterial loads. The ΔΨm decreased from 100% ±
5.8% to 65.4% ± 11.9% in BMMSC 407 line (P <0.01), from
100% ± 5.8% to 89.1% ± 5.2% in BMMSC 412 line
(P <0.05), and from 100% ± 5.8% to 90.0% ± 3.1% in
BMMSC 470 line (P <0.01). However, the lowest bacterial
loads did not induce a significant decrease of ΔΨm in the
BMMSC line 407 when compared with control cells (Fig-
ure 3f). The results clearly indicate that the depolarization
of ΔΨm occurred before major changes in morphology or
in viability as determined by Trypan blue staining were evi-
dent, except with the highest amount of P. aeruginosa
PA01 (Figure 3f). Trypan blue staining results are shown
for the BMMSC line 412 only, but the results were identi-
cal for the two other BMMSC lines. The results also show
that the level of depolarization differed among the three
BMMSC lines. Overall, cell line 407 showed the most dra-
matic depolarization in response to all bacterial strains
which caused significant depolarization of ΔΨm (all except
S. aureus Cowan I), and this line also showed the most dra-
matic response to CCCP. The BMMSC line 412 showed a
somewhat different response to CCCP when compared
with the two other BMMSC lines.
All bacterial strains grew exponentially within 24 hours of
infection, but there were some variations in bacterial
growth during the first 4 hours of infection
Next, we determined bacterial growth in co-culture with
BMMSCs after 4- and 24-hour infection. The initial inocu-
lum of approximately 103 bacteria was seeded onto the 407
BMMSCs. As BMMSCs have been reported to have anti-
microbial effects [36,37], we inoculated bacteria for com-
parison into cell culture medium not containing BMMSCs.
Quantitative counting of bacteria showed that there was
some variation in bacterial numbers in the initial inocula;
however, the amounts of all strains were in the order of
magnitude of 103. All bacterial strains showed exponential
growth within 24 hours of infection when grown on top of
the BMMSCs (Figure 4a). At 24 hours, efficient growth
was also detected when bacteria were incubated in plain
medium (data not shown). However, within the first 4
hours of infection, there were significant differences in
growth between the different strains (Figure 4b). The
amount of P. aeruginosa PA01 increased 139 times during
the first 4 hours of infection when grown on top of the
Table 1 Detailed characterization of human mesenchymal stem cell lines used in this work
hMSC line Positivity, percentage Age in years/Gender
CD90 CD105 CD73 HLA-ABC CD14, CD19, CD34, CD45, HLA-DR
407 98.2 99.8 100 99.5 1.7 57/Female
470 99.8 99.5 99.6 98.8 2.1 70/Female
412 100 99.6 99.9 99.4 1.1 51/Male
The positivity for the particular cell surface antigen was determined according to the negative control by flow cytometry. The panel of negative cell surface
antigens was analyzed as a group. hMSC, human mesenchymal stem cell.
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BMMSCs and 125 times in the medium only. On the other
hand, S. aureus Cowan I showed negligent growth during
the first 4 hours of infection on top of the BMMSCs
whereas in the plain medium the amount of S. aureus
Cowan I increased nine times. S. aureus KK1089 behaved
similarly but grew to consistently higher numbers than
S. aureus Cowan I both in the plain medium (14-fold
increase) and on top of the BMMSCs (over twofold
Figure 1 Total dissipation of human bone marrow-derived mesenchymal stem cells (BMMSCs) by bacterial infection. BMMSCs (line 412)
were infected with bacteria, and after 24-hour incubation the cells were stained with Trypan blue and studied microscopically. (a) Control cells
were viable after 24 hours of cultivation. (b) Pseudomonas aeruginosa PA01-infected BMMSCs show total dissipation at 24 hours with all bacteria
loads. (c) Staphylococcus aureus Cowan I and (d) S. aureus KK1089 formed enormous aggregates and caused the decrease in viability as
determined by Trypan blue. (e) Staphylococcus epidermidis ATCC 14990 and (f) S. epidermidis KK1087 showed total dissipation of BMMSCs at 24
hours of infection. Magnification was 200 × in all panels. Red circles indicate Trypan blue-positive nuclei. Red asterisks indicate the aggregates
produced by S. aureus.
Pietilä et al. Stem Cell Research & Therapy 2012, 3:53
http://stemcellres.com/content/3/6/53
Page 6 of 14
Figure 2 Morphological changes induced in bone marrow-derived mesenchymal stem cells (BMMSCs) by bacterial infection. BMMSCs
(line 412) were infected with bacteria, and after 3- and 6-hour incubation the cells were stained with Trypan blue and studied microscopically.
An inoculum size of approximately 103 bacteria was selected for experiments. (a) Control cells were Trypan blue-negative after 3 and 6 hours of
culture. (b) Pseudomonas aeruginosa PA01-infected cells at 3 and 6 hours. After 6 hours of infection, the morphological changes were seen as a
rounding of the cells and thus they lost their characteristic spindle-like morphology. (c) Staphylococcus aureus Cowan I- and (d) S. aureus
KK1089-infected cells at 3 and 6 hours. Both S. aureus strains formed aggregates after 6 hours of infection. (e) Staphylococcus epidermidis ATCC
14990- and (f) S. epidermidis KK1087-infected cells at 3 and 6 hours. The morphology of the cells remained normal, but some Trypan blue-
positive nuclei were evident. Magnification was 200 × in all panels. Red circles indicate Trypan blue-positive nuclei. Red squares indicate changes
in morphology. Black squares indicate the S. aureus-produced aggregates.
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Figure 3 Depolarization of ΔΨm precedes changes in morphology or plasma membrane integrity of bone marrow-derived
mesenchymal stem cells (BMMSCs). BMMSC lines 412, 407, and 470 were used to study the early changes in ΔΨm and cell viability as
determined by Trypan blue after 4 hours of infection. (a) Trypan blue staining of control cells and response to CCCP (protonophore) that was
used as a positive control. (b) Staphylococcus aureus Cowan I caused slight depolarization of ΔΨm. (c) S. aureus KK1089 induced changes in ΔΨm
and Trypan blue after 4 hours. (d) Staphylococcus epidermidis ATCC 14990 and (e) S. epidermidis KK1087 induced depolarization of ΔΨm. (f)
Depolarization of ΔΨm and Trypan blue staining at 4 hours in Pseudomonas aeruginosa PA01-infected BMMSCs. The fluorescent 595 nm/535 nm
ratio of JC-10 was used to determine ΔΨm, and the 595 nm/535 nm ratios of infected BMMSCs were compared with uninfected control cells.
Results are indicated as mean ± standard deviation of four independent replicates. Magnification was 200 × in all panels. Red circles indicate
Trypan blue-positive nuclei. Black squares indicate the aggregates produced by S. aureus. *P <0.05, **P <0.01, and ***P <0.001 in two-sample t
test between control BMMSCs and infected BMMSCs. ΔΨm, mitochondrial inner membrane potential; CCCP, carbonyl cyanide m-
chlorophenylhydrazone; JC-10, enhanced 5,5’,6,6’-tetrachloro-1,1’,3,3’-tetraethylbenzimidazolcarbocyanine iodide.
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Figure 4 Determination of bacterial growth in co-culture with bone marrow-derived mesenchymal stem cells (BMMSCs). BMMSC line
407 was used to determine the bacterial growth rate in co-culture system. Identical culture conditions without BMMSCs were used as a control.
Pseudomonas aeruginosa PA01, Staphylococcus aureus strains Cowan I and KK1089, and Staphylococcus epidermidis strains ATCC14990 and KK1087
were inoculated at an indicated initial inoculum (0 hours), and bacterial growth was determined by viable counting after 4 and 24 hours of
infection. Series of 10-fold dilutions were prepared from each sample, and the number of colony-forming units (CFU) was determined from at
least two different 10-fold dilutions per sample. (a) All the bacterial strains grew exponentially within 24 hours of infection. However, there were
some differences in growth rate at the beginning of the infection. (b) P. aeruginosa PA01 showed rapid proliferation whereas S. aureus Cowan I
showed negligent growth in the presence of BMMSCs within the first 4 hours of infection. Moreover, both S. aureus strains grew more rapidly in
medium without BMMSCs within the first 4 hours than when compared with bacterial growth on top of the BMMSCs. Both S. epidermidis strains
showed relatively active proliferation within the first 4 hours of infection.
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increase). S. epidermidis ATCC14990 showed over three-
fold increase in bacterial amounts when grown on top of
the BMMSCs and over twofold increase in the medium
only. Also, S. epidermidis KK1087 showed rapid prolifera-
tion within the first 4 hours of infection with CFU fold
changes of nine in co-culture with BMMSCs and nine in
medium only. The results show that S. aureus Cowan I in
particular proliferates slowly during the first 4 hours of
infection. This may explain the inability of the mitochon-
drial assay to detect S. aureus Cowan I-induced cellular
stress within the first 4 hours of infection. We also deter-
mined bacterial proliferation with the initial inocula of
approximately 101 and 102 bacteria per well and noted that
the bacterial growth curves were similar to those obtained
with the highest inoculum (data not shown). The results
also show that growth of the S. aureus strains is signifi-
cantly slower in the presence of BMMSCs than in plain
medium, suggesting that antimicrobial effects from the
cells may hinder their growth.
Mitochondrial assay showed sensitivity for reference
strains used in microbial quality control of cellular
products
Finally, we studied the potential of ΔΨm measurement to
detect bacterium infection-induced changes in viability of
BMMSCs by using certified reference microbial strains
that are widely used in validation of quality control pro-
cesses of cell therapy products. We measured ΔΨm and
bacterial proliferation after infection of BMMSC 407
with the strains P. aeruginosa ATCC9027, S. aureus
ATCC6538, and S. epidermidis ATCC12228. Again, the
bacteria were seeded onto the 407 BMMSCs as well as
into medium not containing BMMSCs, and bacterial
growth was detected by counting CFU after 4 and 24
hours of infection. All bacterial strains grew exponen-
tially within 24 hours of infection (Figure 5a). However,
with reference strains, there were some variations in the
proliferation within the first 4 hours of infection (Figure
5a, b). Interestingly, similar to S. aureus Cowan I and
S. aureus KK1087, S. aureus ATCC6538 grew to signifi-
cantly higher numbers in the absence of BMMSCs (fold
change of 43) than in the presence of cells (fold change
of 7), again suggesting that BMMSCs may have antimi-
crobial effects toward S. aureus (Figure 5b). P. aeruginosa
ATCC9027 showed the highest growth with a fold
change of close to 40 in both culture conditions, whereas
the number of S. epidermidis ATCC12228 even declined
within the first 4 hours of infection. On the other hand,
even though there were differences in bacterial growth at
the beginning, all bacterial strains, including S. epidermi-
dis ATCC12228, grew efficiently during 24 hours of
infection (Figure 5c). S. aureus ATCC6538 continued to
show higher proliferation in medium only (fold change of
6 × 105) when compared with the growth in co-culture
with BMMSCs (fold change of 2 × 105) also during pro-
longed incubation. Similarly, S. epidermidis ATCC12228
proliferated more in medium only (fold change of 7 ×
105) than when cultivated on top of the BMMSCs (fold
change of 2 × 105) (Figure 5c).
In parallel with the determination of bacterial CFU, we
performed the analysis of ΔΨm within 4 hours of infection.
Results are represented as a mean ± SD of four indepen-
dent replicates (Figure 5d). Again, CCCP was used as a
positive control, and it induced total depolarization of
ΔΨm from 100% ± 7.2% to 10.8% ± 1.3% (P <0.001) when
compared with control BMMSCs. P. aeruginosa
ATCC9027, which showed rapid proliferation within the
first 4 hours of infection, also induced significant depolari-
zation of ΔΨm of BMMSCs from 100% ± 7.2% to 71.2% ±
3.7% (P <0.01). In addition, S. aureus ATCC6538 induced
the depolarization of ΔΨm of BMMSCs from 100% ± 7.2%
to 74.9% ± 4.9% (P <0.05) when compared with control
BMMSCs. On the contrary, S. epidermidis ATCC12228
caused only a slight depolarization of ΔΨm of BMMSCs
with the change from 100% ± 7.2% to 91.9% ± 5.6%. Refer-
ence strains behaved somewhat similarly as the strains
used in earlier experiments: after 24 hours of infection,
total dissipation of BMMSCs was evident with P. aerugi-
nosa ATCC9027 and S. epidermidis ATCC12228 whereas
S. aureus ATCC6538 formed enormous aggregates (data
not shown). Moreover, after 6 hours of infection, P. aeru-
ginosa ATCC9027-induced morphological changes in
BMMSCs and S. aureus ATCC6538 formed aggregates as
did the two other S. aureus strains whereas S. epidermidis
ATCC12228 did not induce any visible changes in
BMMSCs (data not shown). These results indicate that the
results from the mitochondrial assay were well in line with
bacterial proliferation within the first 4 hours of infection.
All together, the results with the reference strains support
the results obtained with other bacterial strains.
Discussion
The risk of microbial contamination is well recognized in
the propagation of cells for therapeutic use, but little has
been published to demonstrate and characterize possible
effects of contamination and infection on stem cell prop-
erties and hence on the viability and ultimately on the
safety monitoring of cell therapy products [10,12,14-16].
Accordingly, in the present study, we chose to focus on
the quality control point of view of microbial risks during
the in vitro manufacture of BMMSC-based cellular pro-
ducts. The present study shows that infection of
BMMSCs with even low numbers of bacteria inflicts ser-
ious damage on BMMSC cultures. P. aeruginosa PA01,
P. aeruginosa ATCC9027, and all S. epidermidis strains
caused total dissipation of the BMMSC cultures within
24 hours of infection. S. aureus KK1089, S. aureus ATCC
6538, and S. aureus Cowan I also caused a decrease in
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Figure 5 Comparison of ΔΨm of bone marrow-derived mesenchymal stem cells (BMMSCs) and bacterial viability in co-culture of
BMMSCs with reference strains Pseudomonas aeruginosa ATCC9027, Staphylococcus aureus ATCC6528, and Staphylococcus epidermidis
ATCC12228. BMMSC line 407 was used to determine the bacterial growth kinetics within 4 and 24 hours of infection. P. aeruginosa ATCC9027, S.
aureus ATCC6538, and S. epidermidis ATCC12228 were inoculated in an indicated initial inoculum (0 hours). Medium without BMMSCs was used
as a control. Series of 10-fold dilutions were prepared from each sample, and the number of colony-forming units (CFU) was determined from at
least two different 10-fold dilutions per sample. (a) All of the bacterial strains grew exponentially within 24 hours of infection. (b) There were
some differences in the growth rate of bacteria between different bacterial strains within the first 4 hours of infection. (c) At this time point,
initially slowly proliferated S. epidermidis ATCC12228 also showed efficient bacterial growth. (d) The analysis of ΔΨm was performed in parallel
with the determination of CFUs after 4 hours of infection. The fluorescent 595 nm/535 nm ratio of JC-10 was used to determine ΔΨm, and the
595 nm/535 nm ratios of infected BMMSCs were compared with controls. Results are indicated as mean ± standard deviation of four
independent replicates. *Two-sample t test P values of less than 0.05 when compared between control BMMSCs and infected BMMSCs; **two-
sample t test P values of less than 0.01 when compared between control BMMSCs and infected BMMSCs; ***two-sample t test P values of less
than 0.001 when compared between control BMMSCs and CCCP-treated BMMSCs. ΔΨm, mitochondrial inner membrane potential; CCCP,
carbonyl cyanide m-chlorophenylhydrazone; JC-10, enhanced 5,5’,6,6’-tetrachloro-1,1’,3,3’-tetraethylbenzimidazolcarbocyanine iodide.
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the viability of BMMSCs but behaved somewhat differ-
ently by forming aggregates on the top of BMMSC
monolayers. The exact content of such aggregates
remains unknown at this time but is likely to be due to
the coagulase protein of S. aureus which reacts with pro-
thrombin in blood and enables conversion of fibrinogen
to fibrin, leading to blood clotting [38]. Remnants of coa-
gulation cascade proteins in FBS may react with S. aureus
coagulase and cause aggregation of bacteria. As opposed
to S. aureus, S. epidermidis strains are coagulase-negative,
and this probably explains the absence of aggregates in
samples infected with S. epidermidis.
Even though S. epidermidis generally may be regarded as
less virulent than S. aureus and P. aeruginosa [20], all three
S. epidermidis strains in our study showed definite deleter-
ious effects on BMMSCs, as they also decreased the ΔΨm
and caused dissipation of BMMSCs. The results thus sug-
gest that an opportunistic pathogen, such as S. epidermidis,
is equally hazardous to stem cells as the more virulent
pathogens. Overall, during prolonged incubation, all patho-
gens in the present study promoted somewhat similar
levels of cell destruction regardless of the amount of the
initial inoculum.
Quantitative counting of bacteria showed that P. aerugi-
nosa strains proliferated actively from the beginning but
that other strains showed lower growth. In particular,
S. aureus Cowan I showed almost negligent bacterial
growth within the first 4 hours of infection and seemed to
need more time to adapt to the BMMSC culture medium.
Subsequently, S. aureus Cowan I also began to cause a sig-
nificant decrease in stem cell viability. The damage to
BMMSCs was evident after 6 hours of infection as demon-
strated by traditional live/dead assay, Trypan blue staining,
and monitoring of cellular morphology. As expected,
P. aeruginosa PA01 caused a clear decrease in viability of
BMMSCs after 6 hours of infection and this is well in line
with the rapid bacterial growth within the first 4 hours of
infection. Also, other strains caused an increase in the
number of Trypan blue-stained nuclei of BMMSCs within
the first 6 hours of infection, even though the cellular
damage was not as apparent as with P. aeruginosa strains.
Accordingly, it seems that the signs of pathogen-induced
cellular damage can be seen after 6 hours of infection with
traditional viability methods. The result clearly demon-
strates the risk associated with microbial contamination
and infection. Therefore, methods for validation and qual-
ity control of cell and tissue products call for systematic
monitoring of microbial contamination but also for reli-
able methods for monitoring the viability of the cell pro-
duct and the possible deleterious effects of infection of
stem cells during manufacturing.
Interestingly, the BMMSC line 407 appeared to show
antimicrobial activity toward all three S. aureus strains
studied. Proliferation of S. aureus strains was lower when
grown on top of BMMSCs than in the medium without
the cells. Antimicrobial activity of BMMSCs has recently
been reported in two studies [36,37]. Krasnodembskaya
and colleagues [36] (2010) showed that hMSCs possess
antimicrobial activity toward Escherichia coli K1, P. aeru-
ginosa strain PA103, and S. aureus strain Newman.
Moreover, they showed that intratracheal administration
of hMSCs decreased bacterial growth in an in vivo mouse
model of E. coli pneumonia. This was shown to be
mediated by the secretion of the antimicrobial peptide
LL-37 [36]. Meisel and colleagues [37] (2011) postulated
that hMSCs show antimicrobial activity toward S. aureus
and P. aeruginosa and that the activity is enhanced when
hMSCs are pretreated with interferon gamma (IFN-g). It
was also shown that the antimicrobial function is
mediated by indoleamine 2,3-dioxygenase (IDO) activity,
which also plays a major role in immunosuppression
activity of hMSCs, and is induced by IFN-g [39]. In our
assay conditions, which did not include IFN-g, no signifi-
cant effects toward P. aeruginosa were noted. However,
our results with S. aureus support earlier findings on the
antimicrobial activity of MSCs.
Mitochondria are well-known targets of many bacterial
toxins and compounds [40,41]. It has been demonstrated
that S. aureus directly targets host mitochondria and
induces apoptosis through a-toxins and Panton-Valen-
tine leukocidin [42,43]. In addition, P. aeruginosa and S.
epidermidis have been shown to induce mitochondria-
mediated apoptosis in infected host cells [44,45]. A rele-
vant question, therefore, is whether changes in ΔΨm are
already present before plasma membrane breakout and
morphological changes are detected. In the present
study, we tested the suitability of mitochondrial analyses
as a quality control tool for BMMSCs to detect microbial
infection-induced cellular stress. To perform this experi-
ment in accordance with current microbial quality con-
trol methods, we also used reference strains which are
used in routine quality control studies by cell and tissue
banks. All pathogens except S. aureus Cowan I and
S. epidermidis ATCC12228 caused systematic depolariza-
tion of ΔΨm after only 4 hours of infection. However, at
that time point, only the highest loads of P. aeruginosa
PA01 had induced visible changes in cell membrane
integrity, whereas no major changes were evident with
the other bacteria. The inability of the mitochondrial
assay to detect the impact of S. aureus Cowan I and
S. epidermidis ATCC12228 on the ΔΨm of BMMSCs
may be explained by their negligent growth or even a
decline in bacterial number within the first 4 hours of
infection. Therefore, the results from bacterial growth ana-
lysis are well in line with the results from the mitochon-
drial assay, confirming the sensitivity of the method. The
reason for the negligent or decreased bacterial growth
remains unknown, but it may be that these strains need
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more time for adapting to BMMSC culture conditions
since they both did show exponential growth during a
longer term of infection. Moreover, antimicrobial effects
hindering the proliferation of S. aureus Cowan I in co-cul-
ture with BMMSCs may partly explain the slow growth of
S. aureus Cowan I. In some cases, even the lowest num-
bers of bacteria caused a significant decrease in ΔΨm
when compared with uninfected control stem cells. Thus,
measurement of ΔΨm offers a sensitive method for detec-
tion of microbial damage to cell products. Interestingly,
the three BMMSC lines showed different levels of depolar-
ization of ΔΨm after bacterial infection. The reason for
such a difference remains speculative at this point and
warrants further studies. However, we previously demon-
strated that the level of ΔΨm corresponds to the function
and differentiation potency of BMMSCs [33]. Therefore,
the development of rapid diagnostic tests based on mito-
chondrial function is urgently called for to ensure the via-
bility and potency of stem cell products.
Conclusions
To conclude, co-culture of BMMSCs in the presence of
S. aureus, S. epidermidis, and P. aeruginosa damaged the
viability of BMMSCs as measured by ΔΨm. Such deleter-
ious effects raise significant concerns for the safety and
efficacy of stem cell products for use in clinical therapy.
Additionally, a relatively short exposure to antibiotic-free
medium can reveal a concealed and suppressed infection.
Even low levels of bacterial contamination can be a major
hazard for patients as such, and the deleterious effects of
even short exposure to bacterial pathogens may seriously
alter the efficacy of cellular therapy. On the other hand, by
monitoring of the energy state of stem cell mitochondria,
it is possible to detect changes in infected host cells even
before any other changes are evident by Trypan blue stain-
ing or microscopy for cell morphology. Accordingly, mito-
chondrial analyses show strong potential for quality
control and monitoring of safety and efficacy of cell-based
products. In addition, in compliance with regulatory
demands for microbial safety, techniques to detect low
levels of bacterial contamination in a matter of hours are
urgently called for and should be convenient to incorpo-
rate into testing for mitochondrial function.
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